Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) EBT Margin (2016 - 2026)

Usana Health Sciences has reported EBT Margin over the past 17 years, most recently at 6.18% for Q2 2026.

  • Quarterly EBT Margin fell 53.0% to 6.18% in Q2 2026 from the year-ago period, while the trailing twelve-month figure was 4.35% through Apr 2026, down 318.0% year-over-year, with the annual reading at 4.49% for FY2026, 445.0% down from the prior year.
  • EBT Margin was 6.18% for Q2 2026 at Usana Health Sciences, up from 1.85% in the prior quarter.
  • Over five years, EBT Margin peaked at 13.03% in Q1 2022 and troughed at 0.84% in Q3 2025.
  • The 5-year median for EBT Margin is 9.79% (2022), against an average of 8.88%.
  • Year-over-year, EBT Margin surged 203bps in 2023 and then crashed -845bps in 2025.
  • A 5-year view of EBT Margin shows it stood at 10.0% in 2022, then increased by 20bps to 12.04% in 2023, then plummeted by -59bps to 4.88% in 2024, then tumbled by -83bps to 0.84% in 2025, then surged by 636bps to 6.18% in 2026.
  • Per Business Quant, the three most recent readings for USNA's EBT Margin are 6.18% (Q2 2026), 1.85% (Q1 2026), and 0.84% (Q3 2025).